Recent blog posts
CTR20262833 XJN026 Migraine Disorders Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262833 XJN026 Migraine Disorders Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
CTR20262833 clinical trial report covering XJN026, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
CTR20262794 FXR0906 Hypertriglyceridemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262794 FXR0906 Hypertriglyceridemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
CTR20262794 clinical trial report covering FXR0906, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07719361 FX-111 Metastatic Solid Tumor Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07719361 FX-111 Metastatic Solid Tumor Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07719361 clinical trial report covering FX-111, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
ChiCTR2600128579 CMS-F021 Skin structures and soft tissue infections Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
ChiCTR2600128579 CMS-F021 Skin structures and soft tissue infections Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
ChiCTR2600128579 clinical trial report covering CMS-F021, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07719218 ICF004 Lung Diseases, Interstitial Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07719218 ICF004 Lung Diseases, Interstitial Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07719218 clinical trial report covering ICF004, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07719257 TUL108 Complicated urinary tract infection Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07719257 TUL108 Complicated urinary tract infection Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07719257 clinical trial report covering TUL108, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07719127 Disulfiram High grade glioma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07719127 Disulfiram High grade glioma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07719127 clinical trial report covering Disulfiram, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07719920 HW221043 Advanced Malignant Solid Neoplasm Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07719920 HW221043 Advanced Malignant Solid Neoplasm Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07719920 clinical trial report covering HW221043, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07720843 Belantamab mafodotin Relapse multiple myeloma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07720843 Belantamab mafodotin Relapse multiple myeloma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07720843 clinical trial report covering Belantamab mafodotin, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
CTR20262827 HS-10504 Advanced Lung Non-Small Cell Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262827 HS-10504 Advanced Lung Non-Small Cell Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
CTR20262827 clinical trial report covering HS-10504, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07722585 Nurandociguat Chronic Kidney Diseases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07722585 Nurandociguat Chronic Kidney Diseases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07722585 clinical trial report covering Nurandociguat, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07722299 SAL0167 Hyperlipidemias Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07722299 SAL0167 Hyperlipidemias Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07722299 clinical trial report covering SAL0167, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →